J-104,129
J-104,129 is a chemical compound that acts as a potent and selective phosphodiesterase (PDE) inhibitor. It is primarily used in scientific research to study the role of PDEs in various physiological processes.
Pharmacology[edit | edit source]
J-104,129 is known for its high selectivity towards phosphodiesterase 4 (PDE4) enzymes. PDE4 is an enzyme that breaks down cyclic adenosine monophosphate (cAMP), a secondary messenger involved in many biological processes. By inhibiting PDE4, J-104,129 increases the levels of cAMP within cells, which can lead to various downstream effects.
Mechanism of Action[edit | edit source]
The primary mechanism of action of J-104,129 is the inhibition of PDE4, which prevents the hydrolysis of cAMP to AMP. This results in elevated intracellular cAMP levels, leading to the activation of protein kinase A (PKA) and other cAMP-dependent pathways. These pathways are involved in regulating inflammation, immune responses, and other cellular processes.
Therapeutic Potential[edit | edit source]
While J-104,129 is not used clinically, its ability to modulate cAMP levels makes it a valuable tool in research. PDE4 inhibitors have potential therapeutic applications in treating inflammatory diseases, depression, and chronic obstructive pulmonary disease (COPD).
Research Applications[edit | edit source]
J-104,129 is used extensively in preclinical studies to explore the role of PDE4 in various diseases. It helps in understanding the pathophysiology of conditions where cAMP signaling is disrupted. Researchers use J-104,129 to investigate new therapeutic targets and to develop novel treatments for diseases associated with PDE4 dysregulation.
Safety and Toxicology[edit | edit source]
As with many research chemicals, the safety profile of J-104,129 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. Researchers handling J-104,129 should follow appropriate safety protocols to minimize exposure and potential risks.
Also see[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
